2023 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2023: 48 approvals, 73 patent expiries, 0 Phase 3 milestones.

20212022202320242025

FDA / EMA / MHRA approvals (48)

Patent expiries (73)

Phase 3 readouts (0)

No entries tracked.